Policy

Genetic testing should be available for all breast cancer patients to determine hereditary risk in addition to standard imaging exams, according to new guidelines published Feb. 14 by The American Society of Breast Surgeons. 

Young athletes in New Jersey may soon benefit from a new proposal aimed at drastically reducing concussions and other contact injuries in high school football before and during the season.

More consistent follow-up protocols after benign concordant MRI-guided percutaneous core needle biopsies (MR-PCNBs) could lead to better overall patient care, according to a case study published in the Journal of the American College of Radiology.

The American Society of Radiologic Technologists (ASRT) has shown support for new licensure bills introduced in Missouri and Oklahoma.

The Medical Imaging & Technology Alliance (MITA) has released a new white paper outlining the differences between servicing and remanufacturing activities for medical imaging devices, urging the FDA to clarify its own definitions of the two terms. 

The FDA has published a new letter to providers in radiology, pathology, emergency medicine and several other specialties with updated information related to breast implant associated-anaplastic large cell lymphoma (BIA-ALCL).

New Mexico Gov. Michelle Lujan Grisham has signed the state’s breast density reporting legislation into law.

Emergency room (ER) doctors at Rhode Island Hospital in Providence have been delivered subpoenas charging them with medical misconduct for incorrectly ordering imaging examinations, according to an article published Jan. 30 by Politico.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and American College of Nuclear Medicine (ACNM) submitted a joint statement to the Nuclear Regulatory Commission (NRC) opposing potential changes in the NRC’s training and experience requirements for authorized users to administer radiopharmaceuticals.  

How will the Protecting Access to Medicare Act (PAMA) of 2014 impact emergency department (ED) care in 2020 and beyond? That’s precisely what the authors of a new study published in Radiology wanted to find out.

The 2.3 percent medical device tax, originally implemented as a piece of the Affordable Care Act, is currently suspended until 2020. Could 2019 be the year it gets repealed for good?

The FDA announced that it approved 106 novel medical devices in 2018, surpassing the previous record of 98 set just one year prior. Nine devices also received the agency’s Breakthrough Device Designation.